Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exagen Inc (NQ: XGN ) 2.470 -0.100 (-3.89%) Streaming Delayed Price Updated: 2:48 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Exagen Inc < Previous 1 2 Next > Exagen to Announce Third Quarter 2024 Results on November 12, 2024 October 29, 2024 From Exagen Inc. Via GlobeNewswire Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence October 21, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference September 04, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. (NASDAQ: XGN) Near the Top of Equities by Percentage Gain on 1/29 January 29, 2024 Via Investor Brand Network Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance August 05, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference August 02, 2024 From Exagen Inc. Via GlobeNewswire Exagen Appoints Jeffrey G. Black as New Chief Financial Officer August 01, 2024 From Exagen Inc. Via GlobeNewswire Exagen to Announce Second Quarter 2024 Results on August 5, 2024 July 22, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year May 13, 2024 From Exagen Inc. Via GlobeNewswire Exagen Announces Campaign for Lupus Awareness Month May 06, 2024 From Exagen Inc. Via GlobeNewswire Exagen to Announce First Quarter 2024 Results on May 13, 2024 April 30, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. Announces Changes to the Board of Directors April 26, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results March 18, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum March 08, 2024 From Exagen Inc. Via GlobeNewswire Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024 March 07, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference January 30, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance January 07, 2024 From Exagen Inc. Via GlobeNewswire Exagen Inc. Reports Strong Third Quarter 2023 Results November 13, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers November 09, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 02, 2023 From Exagen Inc. Via GlobeNewswire Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023 October 30, 2023 From Exagen Inc. Via GlobeNewswire Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting September 28, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference September 12, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. Reports Strong Second Quarter 2023 Results August 07, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference July 26, 2023 From Exagen Inc. Via GlobeNewswire Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023 July 25, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. Appoints Paul Kim to Board of Directors July 24, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference May 30, 2023 From Exagen Inc. Via GlobeNewswire Exagen Inc. Reports First Quarter 2023 Results May 15, 2023 Record Physician Demand for AVISE® CTD From Exagen Inc. Via GlobeNewswire Exagen Announces Campaign for Lupus Awareness Month May 01, 2023 From Exagen Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
